Acoramidis beneficial in transthyretin amyloid cardiomyopathy
by Elana GotkineAcoramidis yields a significantly better four-step primary hierarchical outcome, including aspects of mortality and morbidity, than placebo for patients with transthyretin amyloid card
Updated on: March 15,2024
20

Acoramidis beneficial in transthyretin amyloid cardiomyopathy
by Elana GotkineAcoramidis yields a significantly better four-step primary hierarchical outcome, including aspects of mortality and morbidity, than placebo for patients with transthyretin amyloid card
Updated on:March 15,2024
20
